Strength
100 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458014030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
CANAGLIFLOZINApproval Type
New Drug (NDA)
FDA Application
NDA204042On Market Since
3/29/2013
Pharmacological Classes
P-Glycoprotein Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors
Related Drugs
Same classification
MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2097
per ML
ZONISADE 100 MG/5 ML ORAL SUSP
Brand
52652800101•Azurity Pharmaceuticals Inc.
$2.7530
per ML
NEORAL 25 MG GELATIN CAPSULE
Brand
00078024615•Novartis Pharmaceuticals Corporation
$2.8879
per EA
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
SANDIMMUNE 25 MG CAPSULE
Brand
00078024015•Novartis Pharmaceuticals Corporation
$4.3773
per EA
SYNJARDY XR 12.5-1,000 MG TAB
Brand
00597030045•Boehringer Ingelheim Pharmaceuticals Inc.
$5.5938
per EA
SYNJARDY XR 12.5-1,000 MG TAB
Brand
00597030093•Boehringer Ingelheim Pharmaceuticals Inc.
$5.5938
per EA
SYNJARDY 12.5-1,000 MG TABLET
Brand
00597016818•Boehringer Ingelheim Pharmaceuticals Inc.
$5.6030
per EA
SYNJARDY 12.5-1,000 MG TABLET
Brand
00597016860•Boehringer Ingelheim Pharmaceuticals Inc.
$5.6030
per EA
SYNJARDY 5-1,000 MG TABLET
Brand
00597017518•Boehringer Ingelheim Pharmaceuticals Inc.
$5.6034
per EA